NOTA:FRA
Novartis AG
135,00 €
arrow_upward
+1,50%(+2,00) 1D
20-окт., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Open
133,00 €
High
135,00 €
Low
133,00 €
Mkt. cap
312,78 млд
Avg. vol.
33,00
Volume
0,00
52-wk high
145,00 €
52-wk low
102,50 €
No. of employees
75 миң
Open
133,00 €
High
135,00 €
Low
133,00 €
Mkt. cap
312,78 млд
Avg. vol.
33,00
Volume
0,00
52-wk high
145,00 €
52-wk low
102,50 €
No. of employees
75 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
18 саат мурун
Novartis wins FDA approval as Novartis stock stands at EUR 135.15
ad-hoc-news.de
·
20 саат мурун
Novartis stock: October 23 investor call ahead of the Xetra open
CryptoRank
·
1 апта мурун
SAP’s Joule Assistants Are Now Executing Inside Production Business Workflows at Novartis, Nestlé, and PwC
WSJ
·
1 ай мурун
Novartis Stock Drops After Another Trial Setback
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 миң
Founded1996-ж., 7-мар.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websitenovartis.com